Logos Global Management

Latest statistics and disclosures from Logos Global Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Logos Global Management

Logos Global Management holds 50 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cytokinetics Com New (CYTK) 12.7 $136M +30% 1.6M 83.49
 View chart
Apellis Pharmaceuticals (APLS) 10.9 $117M +39% 2.0M 59.86
 View chart
Sarepta Therapeutics Call Option (SRPT) 6.3 $68M +250% 700k 96.43
 View chart
Ideaya Biosciences (IDYA) 6.0 $64M -20% 1.8M 35.58
 View chart
Argenx Se Sponsored Adr (ARGX) 5.1 $55M NEW 145k 380.43
 View chart
Olema Pharmaceuticals (OLMA) 5.1 $54M +17% 4.4M 12.40
 View chart
Immunovant (IMVT) 4.7 $51M -25% 1.2M 42.13
 View chart
Structure Therapeutics Sponsored Ads (GPCR) 4.1 $44M +114% 1.1M 40.76
 View chart
Rocket Pharmaceuticals (RCKT) 3.6 $38M -35% 1.3M 29.97
 View chart
Rayzebio (RYZB) 3.3 $35M NEW 568k 62.17
 View chart
Ambrx Biopharma 2.8 $30M NEW 2.1M 14.24
 View chart
Karuna Therapeutics Ord (KRTX) 2.7 $29M -21% 90k 316.51
 View chart
Immunocore Hldgs Ads (IMCR) 2.6 $27M -11% 400k 68.32
 View chart
Dyne Therapeutics (DYN) 2.3 $25M -13% 1.9M 13.30
 View chart
Morphosys Sponsored Ads Call Option (MOR) 2.3 $25M +160% 2.5M 9.90
 View chart
Inhibrx Call Option (INBX) 2.1 $23M NEW 600k 38.00
 View chart
Annexon (ANNX) 2.1 $23M -6% 5.0M 4.54
 View chart
Akero Therapeutics (AKRO) 1.7 $19M +33% 800k 23.35
 View chart
Ocular Therapeutix (OCUL) 1.7 $18M NEW 4.0M 4.46
 View chart
Design Therapeutics (DSGN) 1.2 $13M 5.0M 2.65
 View chart
Miragen Therapeutics (VRDN) 1.2 $13M -42% 600k 21.78
 View chart
Edgewise Therapeutics (EWTX) 1.0 $10M NEW 950k 10.94
 View chart
Revolution Medicines (RVMD) 0.9 $10M +40% 350k 28.68
 View chart
Acelyrin (SLRN) 0.9 $9.3M NEW 1.3M 7.46
 View chart
Moonlake Immunotherapeutics Class A Ord (MLTX) 0.8 $9.1M NEW 150k 60.39
 View chart
Atyr Pharma Com New (LIFE) 0.8 $8.2M NEW 5.9M 1.41
 View chart
Iovance Biotherapeutics Call Option (IOVA) 0.8 $8.1M 1.0M 8.13
 View chart
Fulcrum Therapeutics (FULC) 0.8 $8.1M NEW 1.2M 6.75
 View chart
Allakos (ALLK) 0.7 $7.9M -37% 2.9M 2.73
 View chart
Zentalis Pharmaceuticals Call Option (ZNTL) 0.7 $7.6M NEW 500k 15.15
 View chart
Tourmaline Bio 0.7 $7.4M NEW 284k 26.18
 View chart
Avidity Biosciences Ord (RNA) 0.7 $7.0M NEW 775k 9.05
 View chart
Silence Therapeutics Ads (SLN) 0.6 $6.9M NEW 400k 17.37
 View chart
Xenon Pharmaceuticals (XENE) 0.6 $6.9M -66% 150k 46.06
 View chart
Neumora Therapeutics (NMRA) 0.6 $6.5M NEW 382k 17.05
 View chart
Arcus Biosciences Incorporated (RCUS) 0.6 $6.2M NEW 325k 19.10
 View chart
Morphic Hldg (MORF) 0.5 $5.8M NEW 200k 28.88
 View chart
Applied Therapeutics (APLT) 0.5 $5.6M NEW 1.7M 3.35
 View chart
Ventyx Biosciences (VTYX) 0.5 $4.9M +788% 2.0M 2.47
 View chart
Icosavax (ICVX) 0.4 $4.7M -89% 300k 15.76
 View chart
Repare Therapeutics Ord (RPTX) 0.4 $4.4M -25% 600k 7.30
 View chart
Compass Pathways Sponsored Ads (CMPS) 0.4 $4.4M -47% 500k 8.75
 View chart
Enliven Therapeutics (ELVN) 0.4 $4.2M 307k 13.84
 View chart
Astria Therapeutics (ATXS) 0.4 $4.2M 545k 7.68
 View chart
Spyre Therapeutics Com New (SYRE) 0.3 $3.2M -28% 150k 21.52
 View chart
Kiniksa Pharmaceuticals Com Cl A (KNSA) 0.2 $2.6M NEW 150k 17.54
 View chart
Delcath Sys Com New (DCTH) 0.1 $1.2M -71% 300k 4.16
 View chart
Io Biotech (IOBT) 0.1 $928k 494k 1.88
 View chart
Immunic (IMUX) 0.1 $632k 421k 1.50
 View chart
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) 0.0 $4.0k 67k 0.06
 View chart

Past Filings by Logos Global Management

SEC 13F filings are viewable for Logos Global Management going back to 2019

View all past filings